Conference Coverage

Polypill Improves Cardiovascular Health in UMPIRE


 

AT THE ANNUAL SCIENTIFIC SESSIONS OF THE AMERICAN HEART ASSOCIATION

While most of the clinical trials, past and present, have taken place in low-income countries, the polypill is also under study in populations in the United States, Canada, Australia, and other relatively well-off nations, he pointed out.

UMPIRE was funded by the European Commission. Dr. Thom and Dr. Tonkin reported having no financial conflicts.

Pages

Recommended Reading

Guidelines Update Approaches to Stable Ischemic Heart Disease
MDedge Family Medicine
Coumadin With an Aspirin Chaser
MDedge Family Medicine
In Type 1 Diabetes, Cardiac Measures Improved After Pancreas Transplant
MDedge Family Medicine
DPP-4 Inhibitors for Diabetes May Cut Cardiovascular Risk
MDedge Family Medicine
Real-World HF Findings at Odds With Clinical Trials
MDedge Family Medicine
New Model Tops Others for Predicting Heart Disease in RA
MDedge Family Medicine
Dalcetrapib Boosts HDL Without Benefiting Patients
MDedge Family Medicine
Hodgkin's Lymphoma Radiation Linked to Cardiovascular Disease
MDedge Family Medicine
Dark Chocolate Improves Heart Failure Markers ... Mmmm!
MDedge Family Medicine
Ranbaxy Recalls Atorvastatin
MDedge Family Medicine